C12N 2310/3181
Peptide nucleic acid, pna
Official title: Peptide nucleic acid, PNA
C12N2310/3181 (Peptide nucleic acid, pna) appears on 291 US grants and 501 published applications in this corpus.
Search patents in C12N- Granted patents
- 291
- Published applications
- 501
- Assignees
- 198
- Inventors
- 750
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 5 | 0 |
| 1999 | 12 | 0 |
| 2000 | 6 | 0 |
| 2001 | 13 | 2 |
| 2002 | 5 | 8 |
| 2003 | 5 | 29 |
| 2004 | 7 | 22 |
| 2005 | 5 | 13 |
| 2006 | 8 | 11 |
| 2007 | 0 | 4 |
| 2008 | 5 | 9 |
| 2009 | 5 | 13 |
| 2010 | 7 | 10 |
| 2011 | 4 | 14 |
| 2012 | 7 | 19 |
| 2013 | 7 | 14 |
| 2014 | 8 | 27 |
| 2015 | 14 | 31 |
| 2016 | 24 | 26 |
| 2017 | 16 | 30 |
| 2018 | 21 | 23 |
| 2019 | 14 | 31 |
| 2020 | 19 | 22 |
| 2021 | 13 | 27 |
| 2022 | 15 | 28 |
| 2023 | 11 | 33 |
| 2024 | 12 | 27 |
| 2025 | 11 | 12 |
| 2026 | 10 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Antisense molecules and methods for treating pathologies18 Aug 2026US 12,709,749 B2The University of Western Australia
- RNA G-quadruplex structure in pre-miRNA-1229 as a therapeutic target for Alzheimer's disease and various cancers11 Aug 2026US 12,703,863 B2Duquesne University of the Holy Spirit
- Composition of a therapeutic oligomer26 May 2026US 12,636,303 B2
- Exon skipping by peptide nucleic acid derivatives12 May 2026US 12,624,068 B2OliPass Corporation
- Compositions and methods for improved gene editing28 Apr 2026US 12,612,619 B2University of Massachusetts
- Methods of minimising effects of smoke exposure8 Oct 2026US 2026/0308597 A1Rage Biotech Pty Ltd
- Modulation of Dystrophia Myotonica-Protein Kinase (DMPK) Expression1 Oct 2026US 2026/0297587 A1Ionis Pharmaceuticals, Inc.
- Administration of oligonucleotides24 Sep 2026US 2026/0286366 A1Rage Biotech Pty Ltd
- Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2C Using Exon Skipping10 Sep 2026US 2026/0265760 A1Northwestern University
- Catalytic nucleic acid-based genetic engineering method27 Aug 2026US 2026/0250677 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- Peptide nucleic acids763US 5,539,082 A1996
- Oligoribonucleotides and ribonucleases for cleaving RNA486US 6,107,094 AIsis Pharmaceuticals, Inc. · 2000
- Oligoribonucleotides for cleaving RNA385US 5,898,031 AIsis Pharmaceuticals, Inc. · 1999
- Alteration of cellular behavior by antisense modulation of mRNA processing259US 6,210,892 B1Isis Pharmaceuticals, Inc. · 2001
- Antisense modulation of BCL-X expression218US 6,172,216 B2Isis Pharmaceuticals, Inc. · 2001